Answer
Dasatinib inhibits BCR-ABL kinase, SRC family kinases, and other selected oncogenic kinases including c-KIT, ephrin (EPH) receptor kinases and PDGFβ receptor.
Sources for this answer
- Dasatinib 80mg film-coated tabletsZentiva · emc · SmPC §5.1 Pharmacodynamic properties · Version 12Document updated
Sources checked